Therapeutic Advances in Musculoskeletal Disease

Papers
(The TQCC of Therapeutic Advances in Musculoskeletal Disease is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Is there wastage in the research resources for ankylosing spondylitis? An analysis of clinical trial discontinuation and nonpublication outcome158
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment85
Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI45
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis42
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study41
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis37
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review36
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data33
Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)32
Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis32
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients31
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients30
Cardio-rheumatology: integrated care and the opportunities for personalized medicine30
Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry29
Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials29
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs26
Reduced bone mineral density in patients with idiopathic inflammatory myopathies: a case-control study26
From advanced imaging to molecular insights: the state of the art in omics for axial spondyloarthritis26
Calcineurin inhibitors in systemic sclerosis – a systematic literature review26
Health disparities in rheumatoid arthritis25
Wearable transcutaneous electrical nerve stimulation (actiTENS®) is effective and safe for the treatment of knee osteoarthritis pain: a randomized controlled trial versus weak opioids24
Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors24
Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome22
Bone fragility: conceptual framework, therapeutic implications, and COVID-19-related issues22
Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study20
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout19
A glimpse into the future of systemic lupus erythematosus19
Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study19
Early knee OA definition–what do we know at this stage? An imaging perspective18
T-score discordance between hip and lumbar spine: risk factors and clinical implications18
Stromal vascular fraction therapy for knee osteoarthritis: a systematic review18
Future challenges in rheumatology – is telemedicine the solution?18
Sjögren syndrome: looking forward to the future18
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial17
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses17
Role of imaging for eligibility and safety of a-NGF clinical trials17
Development and evaluation of a multivariable prediction model for clinical improvement in an established cohort of Colombian rheumatoid arthritis patients17
Evaluation of local tissue peri-implant reaction in total knee arthroplasty failure cases17
Advanced imaging techniques in crystal arthritis17
Systemic lupus erythematosus is associated with increased risk of Parkinson’s disease16
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care16
Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA16
Gout increases length of stay in patients hospitalized for heart failure exacerbation16
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers15
Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis15
MRI lesions in SpA: a comparison with noninflammatory back pain using propensity score adjustment method15
Gout therapy updated14
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)14
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multipl14
An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis14
A novel infrapatellar approach of ultrasound-guided intra-articular injection of the knee from both lateral and medial side: a case series14
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review14
The analysis of the pulmonary domain involvement in Sjögren’s disease13
Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort13
Precision medicine in axial spondyloarthritis: current opportunities and future perspectives13
Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case–control study13
Latest insights in disease-modifying osteoarthritis drugs development12
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy12
Precision medicine using molecular-target drugs in psoriatic arthritis12
Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy12
A broad look into the future of rheumatoid arthritis12
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose12
A glance into the future of myositis therapy12
Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus12
SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD11
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)11
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthr11
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic11
Increased risks of aortic regurgitation and atrial fibrillation in radiographic axial spondyloarthritis patients: a 10-year nationwide cohort study11
1.4662020206451